Showing 3,521 - 3,540 results of 4,404 for search '"Clinical trial"', query time: 0.09s Refine Results
  1. 3521

    Bimatoprost Intracameral Implant (Durysta®): A New Era in Glaucoma Management Through Sustained-Release Innovation by Vagiakis I, Papadopoulou EP, Amaxilati E, Tsiropoulos GN, Konstas AG, Panos GD

    Published 2025-01-01
    “…This review evaluates its pharmacology, efficacy, and safety, using data from pivotal clinical trials and recent real-world studies. The implant achieves IOP reductions comparable to topical prostaglandin analogs, with benefits for patient adherence and fewer common side effects. …”
    Get full text
    Article
  2. 3522

    Clinical implications of Delphian lymph node metastasis in papillary thyroid carcinoma: a single-institution study, systemic review and meta-analysis by Bin Wang, Xing-zhu Wen, Wei Zhang, Ming Qiu

    Published 2019-08-01
    “…Trial registration The clinical study was retrospectively registered to UMIN clinical trials registry (the registry number: UMIN000033835).…”
    Get full text
    Article
  3. 3523

    Systemic reviews and meta-analysis of the use of midodrine in hepatorenal syndrome by Prem Balaji Reddy Lankapothu, Shrinidhi B., Satish Kumar M., Magesh Kumar S.

    Published 2024-09-01
    “…However, significant, well-designed clinical trials are needed to determine optimal dosage, duration, and pharmacological side effects. …”
    Get full text
    Article
  4. 3524

    Biological Evaluation of Platinum(II) Sulfonamido Complexes: Synthesis, Characterization, Cytotoxicity, and Biological Imaging by Charini Maladeniya, Taniya Darshani, Sameera R. Samarakoon, Frank R. Fronczek, W. M. C. Sameera, Inoka C. Perera, Theshini Perera

    Published 2022-01-01
    “…Platinum-based compounds are actively used in clinical trials as anticancer agents. In this study, two novel platinum complexes, (C1 = [PtCl2(N(SO2quin)dpa)], C2 = [PtCl2(N(SO2azobenz)dpa)]) containing quinoline and azobenzene appended dipicolylamine sulfonamide ligands were synthesized in good yield. …”
    Get full text
    Article
  5. 3525

    Intra-articular corticosteroids for treatment of temporomandibular joint internal disorders: protocol for systematic review and network meta-analysis by Aurelio Tobias, Daniela Torres, Carlos Zaror, Verónica Iturriaga

    Published 2020-09-01
    “…There are several studies on minimally invasive therapy for internal TMJ disorders; however, none compares the effectiveness of the different intra-articular corticosteroids to each other.The purpose of this study is to evaluate the effectiveness of the different intra-articular corticosteroids for the treatment of internal disorders of the TMJ and compare them to each other or to other minimally invasive therapies.Methods and analysis A systematic search will be carried out up to December 2019 in the electronic databases: Medline, Cochrane Library, EMBASE, SCOPUS and LILACS.Randomised clinical trials evaluating patients with internal disorders of the TMJ, with intra-articular corticosteroid therapy and comparing these to each other and/or to other minimally invasive therapy will be included. …”
    Get full text
    Article
  6. 3526

    Treatment for neovascular age-related macular degeneration: reasonable expectations of physicians and patients by A.B. Durasov

    Published 2021-09-01
    “…Treatment outcomes are not always in line with the results of randomized clinical trials and do not meet the expectations for therapy whose success is assessed differently by patients and physicians. …”
    Get full text
    Article
  7. 3527

    Polygenic risk score for acute rejection based on donor-recipient non-HLA genotype mismatch. by Rui Cao, David P Schladt, Casey Dorr, Arthur J Matas, William S Oetting, Pamala A Jacobson, Ajay Israni, Jinbo Chen, Weihua Guan

    Published 2024-01-01
    “…Trial registry: Deterioration of Kidney Allograft Function Genomics (NCT00270712) and Genomics of Kidney Transplantation (NCT01714440) are registered on ClinicalTrials.gov.…”
    Get full text
    Article
  8. 3528

    Species Differences in the Biotransformation of Aflatoxin B1: Primary Determinants of Relative Carcinogenic Potency in Different Animal Species by David L. Eaton, David E. Williams, Roger A. Coulombe

    Published 2025-01-01
    “…John Groopman has played a leading role in every step of the way—from initial laboratory studies on specific AFB1 metabolites to the application of molecular biomarkers in epidemiological studies associating dietary AFB1 exposure with liver cancer, and the design and conduct of chemoprevention clinical trials to reduce cancer risk from unavoidable aflatoxin exposures by alteration of specific AFB1 biotransformation pathways. …”
    Get full text
    Article
  9. 3529

    Effects of a Distributed Form of Constraint-Induced Movement Therapy for Clinical Application: The Keys Treatment Protocol by Sarah dos Anjos, Mary Bowman, David Morris

    Published 2025-01-01
    “…These findings support its feasibility and potential for outpatient stroke rehabilitation (ClinicalTrials.gov Registration: NCT05311384).…”
    Get full text
    Article
  10. 3530

    Immunotherapy versus targeted therapy in management of recurrent squamous cell carcinoma of oral tongue by Nadimul Hoda, Aastha Moza, K.P. Amith, K.S. Sabitha

    Published 2024-06-01
    “…Our analysis consisted of both the forms of therapies where in immunotherapy precedes targeted therapy in terms of confirmed clinical trials. Conclusion: This newer modality of the cancer treatment forms the fourth pillar supporting surgery, chemotherapy, and radiotherapy. …”
    Get full text
    Article
  11. 3531

    Dual Role of Bacteria in Carcinoma: Stimulation and Inhibition by Suad A Al-Hilu, Wisam H Al-Shujairi

    Published 2020-01-01
    “…Finally, we provide past and ongoing clinical trials that include bacteria targeting tumors.…”
    Get full text
    Article
  12. 3532
  13. 3533
  14. 3534

    Neuromyelitis optica spectrum disorder: epidemiology, pathogenesis, diagnosis, treatment, and prognosis by J. Čemerkaitė, I. Kaukėnaitė, R. Liutkevičienė

    Published 2021-03-01
    “…Recent results of randomised clinical trials with monoclonal anti- bodies such as inebilizumab, satralizumab, tocilizumab, and eculizumab have proved their efficacy and safety in maintenance treatment of NMOSD. …”
    Get full text
    Article
  15. 3535
  16. 3536

    Abnormal Esophageal Scintigraphy Associates With a Distinct Clinical Phenotype in Patients With Systemic Sclerosis by Antonio D. Salas, Lisa R. Yanek, Laura K. Hummers, Ami A. Shah, Zsuzsanna H. McMahan

    Published 2025-01-01
    “…University of California Los Angeles Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 scores measured GI symptoms, Medsger scores measured physician‐assessed SSc disease severity, and the Composite Autonomic Symptom Score 31 survey evaluated dysautonomia symptoms. …”
    Get full text
    Article
  17. 3537

    Electronic patient-reported outcome measures using mobile health technology in rheumatology: A scoping review. by Jaclyn Shelton, Sierra Casey, Nathan Puhl, Jeanette Buckingham, Elaine Yacyshyn

    Published 2021-01-01
    “…A total of 39 (56%) studies directly evaluated the feasibility of ePROMs in clinical practice, 19 (27%) were clinical trials that used ePROMs as study endpoints, 9 (13%) were focus groups or surveys on smartphone application development, and 3 (4%) did not fit into one defined category.…”
    Get full text
    Article
  18. 3538
  19. 3539

    Promising Therapeutic Functions of Bone Marrow Mesenchymal Stem Cells Derived-Exosome in Asthma by Jia-Ying Yuan, Xiang-Yun Wang, Zhi-Ying Tong, Yu-Chao Dong, Jia-Yi Zhao, Yi Zhang, Yan Shang

    Published 2022-01-01
    “…However, BMMSC-Exo still lacked more clinical trials for evaluating the effects on asthma, and the technology of extraction and purification still needs to be improved for wide use. …”
    Get full text
    Article
  20. 3540

    How pragmatic are randomised controlled trials evaluating minimally invasive surgery for oesophageal cancer? A methodological review of trial design using the Pragmatic-Explanatory... by Natalie S Blencowe, Jane Blazeby, Sian Cousins, Katy Chalmers

    Published 2024-12-01
    “…Abstracts, pilot and feasibility studies, and systematic reviews were excluded.Sources of evidence Three sequential searches of Ovid MEDLINE, Embase and CENTRAL electronic databases and clinical trials registry databases.Charting methods Two independent reviewers screened the articles and used appropriate, validated tools (Pragmatic-Explanatory Continuum Indicator Summary-2 (PRECIS-2) and Risk of Bias 2) to assess study quality. …”
    Get full text
    Article